Analysis of KIAA1549-BRAF fusion gene expression and IDH1/IDH2 mutations in low grade pediatric astrocytomas

Journal of Neuro-Oncology

Volumn 117, Issue 2, 2014, Pages 235-242

  Cruz, Gabriela Rampazzo ^a   Dias Oliveira, Indhira ^a   Moraes, Laís ^a   Del Giudice Paniago, Mário ^a   De Seixas Alves, Maria Teresa ^a   Capellano, Andrea Maria ^a   Saba Silva, Nasjla ^a   Cavalheiro, Sérgio ^a   Cerutti, Janete Maria ^a   Toledo, Silvia Regina Caminada ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Astrocytoma; Gene expression; IDH1; IDH2; KIAA1549 BRAF; Sequencing

Indexed keywords

B RAF KINASE; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN MYB; BRAF PROTEIN, HUMAN; IDH1 PROTEIN, HUMAN; ISOCITRATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE 2, HUMAN; ONCOPROTEIN;

ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVATION; EXON; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE FUSION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; OVERALL SURVIVAL; PILOCYTIC ASTROCYTOMA; POLYMERASE CHAIN REACTION; ADOLESCENT; CHILD; GENETICS; INFANT; MUTATION; NEWBORN; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; YOUNG ADULT;

ADOLESCENT; ASTROCYTOMA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; ISOCITRATE DEHYDROGENASE; MALE; MUTATION; NEOPLASM GRADING; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS B-RAF; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84901611641     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1398-1     Document Type: Article

References (37)

1. Rickert CH, Paulus W (2001) Epidemiology of central nervous system tumours in childhood and adolescence based on new WHO classification. Childs Nerv Syst 17:503-511
2. Jeuken JWM, Wesseling P (2010) MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential. J Pathol 222:324-328
3. Ptister S, Janzarik WG, Remk M et al (2008) BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest 118:1739-1749
4. Ward SJ, Karakoula K, Phipps KP et al (2010) Cytogenetic analysis of paediatric astrocytoma using comparative genomic hybridization and fluorescence in situ hybridization. J Neurooncol 98:305-318
5. Jones DT, Kocialkowski S, Liu L et al (2008) Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68:8673-8677
6. Sievert AJ, Jackson EM, Gai X et al (2009) Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene. Brain Pathol 19:449-458
7. Forshew T, Tatevossian RG, Lawson AR et al (2009) Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol 218:172-181
8. Lin A, Rodriguez FJ, Karajannis MA et al (2012) BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549: BRAF fusion variants. J Neuropathol Exp Neurol 71:66-72
9. Schindler G, Capper D, Meyer J et al (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121:397-405
10. Bar EE, Lin A, Tihan T et al (2008) Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma. J Neuropathol Exp Neurol 67:878-887
11. Jacob K, Albrecht S, Sollier C et al (2009) Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours. Br J Cancer 101:722-733
12. Jones DT, Kocialkowski S, Liu L et al (2009) Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma. Oncogene 28:2119-2123
13. Hawkins C, Walker E, Mohamed N et al (2011) BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric low-grade astrocytoma. Clin Cancer Res 17:4790-4798
14. Lawson AR, Hindley GF, Forshew T et al (2011) RAF gene fusion breakpoints in pediatric brain tumors are characterized by significant enrichment of sequence microhomology. Genome Res 21:505-514
15. Sadighi Z, Slopis J (2013) Pilocytic astrocytoma: a disease with evolving molecular heterogeneity. J Child Neurol 28(5):625-632
16. Nagase T, Kikuno R, Nakayama M et al (2000) Prediction of the coding sequences of unidentified human genes XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res 7:273-281
17. Tatevossian RG, Lawson AR, Forshew T et al (2010) MAPK pathway activation and the origins of pediatric low-grade astrocytomas. J Cell Physiol 222:509-514
18. Horbinski C (2013) To BRAF or Not to BRAF: is that even a question anymore? J Neuropathol Exp Neurol 72(1):2-7
19. Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949-954
20. Eisenhardt AE, Olbrich H, Roring M et al (2011) Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma. Int J Cancer 129:2297-2303
21. Ramkissoon LA, Horowitz PM, Craig JM et al (2013) Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1. Proc Natl Acad Sci USA 110(20):8188-8193
22. Zhang J, Wu G, Miller CP et al (2013) Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet 45(6):602-612
23. Chotirat S, Thongnoppakhun W, Promsuwicha O et al (2012) Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients. J Hematol Oncol 5:5
24. Prensner JR, Chinnaiyan AM (2011) Metabolism unhinged: IDH mutation in cancer. Nat Med 17:291-293
25. Kloosterhof NK, Bralten LBC, Dubbink HJ, French PJ, van den Bent MJ (2011) Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma? Lancet Oncol 12:83-91
26. Parsons DW, Jones S, Zhang X, Lin JC, Leary LJ, Angenendt P et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-1812
27. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765-773
28. Yen KE, Bittinger MA, Su SM et al (2010) Cancer-associated IDH mutations: biomarker and therapeutic opportunities. Oncogene 29:6409-6417
29. Oler G, Ebina KN, Michaluart P Jr et al (2005) Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis reveals a new mutation in metastasis. Clin Endocrinol (Oxf) 62(4):509-511
30. Hermely JF, Bastos AU, Cerutti J (2010) Identification of several novel non-p.R132 IDH1 variants in thyroid carcinomas. Eur J Endocrinol 163:747-755
31. Korshunov A, Meyer J, Capper D, Christians A, Remke M et al (2009) Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma. Acta Neuropathol 118:401-405
32. Jones DT (2009) Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549: BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma. Oncogene 28:2119Y23
33. Cin H, Meyer C, Herr R et al (2011) Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma. Acta Neuropathol 121:763Y74
34. Horbinski C, Nikiforova MN, Hagenkord JM et al (2012) Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas. Neuro Oncol 14:777Y89
35. Badiali M, Gleize V, Paris S, Moi L, Elhouadani S, Arcella A et al (2012) KIAA1549-BRAF fusions and IDH mutations can coexist in diffuse gliomas of adults. Brain Pathol 22(6):841-847
36. Pollack IF, Hamilton RL, Sobol RW, Nikiforova MN, Lyons-Weiler MA, LaFramboise WA et al (2011) IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's Oncology Group. Childs Nerv Syst 27(1):87-94
37. Dougherty MJ, Santi M, Brose MS, Ma C, Resnick AC, Sievert AJ, Storm PB, Biegel JA (2010) Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. Neuro Oncol 12(7):621-630